Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
B2007 Pizotifen MalateTarget: 5-HT2 Receptors|D2 ReceptorsSummary: 5-HT receptor antagonist
-
B2231 Amitriptyline HClTarget: Trk Receptors|5-HT2 Receptors|Norepinephrine transporter|5-HT TransportersSummary: Serotonin /norepinephrine receptor/5-HT4/5-HT2 inhibitor
-
B1548 Cyclizine 2HClTarget: Histamine H1 ReceptorsSummary: Histamine H1 receptor antagonist
-
B2236 DesvenlafaxineTarget: 5-HT Transporters|Norepinephrine transportersSummary: serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor
-
B1549 Hydroxyzine 2HClTarget: Histamine H1 ReceptorsSummary: Histamine H1-receptor antagonist
-
B1574 JNJ-7777120Target: Histamine H4 ReceptorsSummary: Histamine H4 receptor antagonist
-
B1458 LumiracoxibTarget: COXSummary: Novel, selective COX-2 inhibitor
-
B1563 Pemirolast potassiumTarget: Histamine H1 ReceptorsSummary: Histamine H1 receptor antagonist
-
B1441 LornoxicamTarget: COXSummary: COX-1/COX-2 inhibitor
-
B1564 RanitidineTarget: Histamine H2 ReceptorsSummary: Histamine H2-receptor antagonist